Titre : Fièvre jaune

Fièvre jaune : Questions médicales fréquentes

Termes MeSH sélectionnés :

Program Evaluation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Fièvre jaune : Questions médicales les plus fréquentes", "headline": "Fièvre jaune : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Fièvre jaune : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-06", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Fièvre jaune" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Fièvres hémorragiques virales", "url": "https://questionsmedicales.fr/mesh/D006482", "about": { "@type": "MedicalCondition", "name": "Fièvres hémorragiques virales", "code": { "@type": "MedicalCode", "code": "D006482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.417" } } }, "about": { "@type": "MedicalCondition", "name": "Fièvre jaune", "alternateName": "Yellow Fever", "code": { "@type": "MedicalCode", "code": "D015004", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Pedro Augusto Alves", "url": "https://questionsmedicales.fr/author/Pedro%20Augusto%20Alves", "affiliation": { "@type": "Organization", "name": "Instituto René Rachou/Fundação Oswaldo Cruz, 30190-002 Belo Horizonte, Minas Gerais, Brazil." } }, { "@type": "Person", "name": "Erna Geessien Kroon", "url": "https://questionsmedicales.fr/author/Erna%20Geessien%20Kroon", "affiliation": { "@type": "Organization", "name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil." } }, { "@type": "Person", "name": "Betânia Paiva Drumond", "url": "https://questionsmedicales.fr/author/Bet%C3%A2nia%20Paiva%20Drumond", "affiliation": { "@type": "Organization", "name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil." } }, { "@type": "Person", "name": "Anna-Bella Failloux", "url": "https://questionsmedicales.fr/author/Anna-Bella%20Failloux", "affiliation": { "@type": "Organization", "name": "Institut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France. anna-bella.failloux@pasteur.fr." } }, { "@type": "Person", "name": "Laurence Cibrelus", "url": "https://questionsmedicales.fr/author/Laurence%20Cibrelus", "affiliation": { "@type": "Organization", "name": "World Health Organisation, Geneva, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evaluating the design and implementation of Kazakhstan's workfare program.", "datePublished": "2023-05-01", "url": "https://questionsmedicales.fr/article/37149977", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.evalprogplan.2023.102301" } }, { "@type": "ScholarlyArticle", "name": "Safer opioid supply: qualitative program evaluation.", "datePublished": "2023-04-20", "url": "https://questionsmedicales.fr/article/37081500", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12954-023-00776-z" } }, { "@type": "ScholarlyArticle", "name": "The directors of resident support program: a program evaluation of a resident well-being and support innovation.", "datePublished": "2024-10-17", "url": "https://questionsmedicales.fr/article/39420361", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-024-06176-6" } }, { "@type": "ScholarlyArticle", "name": "Impact of a short-term pharmacy study abroad Program: student outcomes and program evaluation.", "datePublished": "2024-10-02", "url": "https://questionsmedicales.fr/article/39358753", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13104-024-06919-0" } }, { "@type": "ScholarlyArticle", "name": "A mixed-methods program evaluation of the Alda Healthcare Experience- a program to improve healthcare team communication.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36578023", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-022-03972-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Maladies virales", "item": "https://questionsmedicales.fr/mesh/D014777" }, { "@type": "ListItem", "position": 4, "name": "Infections à virus à ARN", "item": "https://questionsmedicales.fr/mesh/D012327" }, { "@type": "ListItem", "position": 5, "name": "Fièvres hémorragiques virales", "item": "https://questionsmedicales.fr/mesh/D006482" }, { "@type": "ListItem", "position": 6, "name": "Fièvre jaune", "item": "https://questionsmedicales.fr/mesh/D015004" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Fièvre jaune - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Fièvre jaune", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Fièvre jaune", "description": "Comment diagnostique-t-on la fièvre jaune ?\nQuels tests sont utilisés pour confirmer la fièvre jaune ?\nQuels symptômes indiquent une fièvre jaune ?\nLa fièvre jaune peut-elle être confondue avec d'autres maladies ?\nQuel rôle joue l'historique de voyage dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Program+Evaluation&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Fièvre jaune", "description": "Quels sont les premiers symptômes de la fièvre jaune ?\nLa jaunisse est-elle un symptôme de la fièvre jaune ?\nQuels symptômes indiquent une forme sévère de la maladie ?\nLes symptômes de la fièvre jaune évoluent-ils rapidement ?\nPeut-on avoir des symptômes sans être infecté ?", "url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Program+Evaluation&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Fièvre jaune", "description": "Comment se protéger contre la fièvre jaune ?\nLa vaccination est-elle efficace contre la fièvre jaune ?\nÀ quel âge peut-on se faire vacciner contre la fièvre jaune ?\nFaut-il un certificat de vaccination pour voyager ?\nLes moustiquaires sont-elles utiles pour la prévention ?", "url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Program+Evaluation&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Fièvre jaune", "description": "Quel est le traitement principal pour la fièvre jaune ?\nLes antibiotiques sont-ils efficaces contre la fièvre jaune ?\nComment gérer la déshydratation due à la fièvre jaune ?\nDes soins intensifs sont-ils nécessaires pour les cas graves ?\nPeut-on prévenir la fièvre jaune par des traitements ?", "url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Program+Evaluation&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Fièvre jaune", "description": "Quelles sont les complications possibles de la fièvre jaune ?\nLa fièvre jaune peut-elle entraîner la mort ?\nQuels organes peuvent être affectés par la fièvre jaune ?\nLes complications surviennent-elles rapidement ?\nPeut-on récupérer complètement après des complications ?", "url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Program+Evaluation&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Fièvre jaune", "description": "Qui est le plus à risque de contracter la fièvre jaune ?\nLes voyageurs doivent-ils se faire vacciner avant de partir ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes conditions de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Program+Evaluation&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la fièvre jaune ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur les symptômes cliniques et des tests sanguins pour détecter le virus." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer la fièvre jaune ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et la PCR sont utilisés pour confirmer la présence du virus." } }, { "@type": "Question", "name": "Quels symptômes indiquent une fièvre jaune ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, douleurs musculaires, et jaunisse sont des symptômes clés." } }, { "@type": "Question", "name": "La fièvre jaune peut-elle être confondue avec d'autres maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec la dengue ou l'hépatite virale." } }, { "@type": "Question", "name": "Quel rôle joue l'historique de voyage dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un historique de voyage dans des zones endémiques est crucial pour le diagnostic." } }, { "@type": "Question", "name": "Quels sont les premiers symptômes de la fièvre jaune ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les premiers symptômes incluent fièvre, frissons, et douleurs musculaires." } }, { "@type": "Question", "name": "La jaunisse est-elle un symptôme de la fièvre jaune ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la jaunisse apparaît souvent dans les cas avancés de fièvre jaune." } }, { "@type": "Question", "name": "Quels symptômes indiquent une forme sévère de la maladie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements, des douleurs abdominales et une défaillance organique signalent une forme sévère." } }, { "@type": "Question", "name": "Les symptômes de la fièvre jaune évoluent-ils rapidement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent évoluer rapidement, nécessitant une attention médicale urgente." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans être infecté ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes similaires peuvent apparaître sans infection, nécessitant un diagnostic précis." } }, { "@type": "Question", "name": "Comment se protéger contre la fièvre jaune ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des répulsifs, portez des vêtements longs et évitez les zones à moustiques." } }, { "@type": "Question", "name": "La vaccination est-elle efficace contre la fièvre jaune ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination est très efficace et recommandée pour les voyageurs dans les zones à risque." } }, { "@type": "Question", "name": "À quel âge peut-on se faire vacciner contre la fièvre jaune ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination est recommandée à partir de 9 mois." } }, { "@type": "Question", "name": "Faut-il un certificat de vaccination pour voyager ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un certificat de vaccination peut être exigé pour entrer dans certains pays." } }, { "@type": "Question", "name": "Les moustiquaires sont-elles utiles pour la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les moustiquaires traitées sont efficaces pour réduire les piqûres de moustiques." } }, { "@type": "Question", "name": "Quel est le traitement principal pour la fièvre jaune ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre la fièvre jaune ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces car la fièvre jaune est causée par un virus." } }, { "@type": "Question", "name": "Comment gérer la déshydratation due à la fièvre jaune ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation par voie intraveineuse est essentielle pour gérer la déshydratation." } }, { "@type": "Question", "name": "Des soins intensifs sont-ils nécessaires pour les cas graves ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cas graves peuvent nécessiter des soins intensifs pour surveiller les organes." } }, { "@type": "Question", "name": "Peut-on prévenir la fièvre jaune par des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La prévention repose principalement sur la vaccination, pas sur des traitements." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la fièvre jaune ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance hépatique, les saignements et le choc." } }, { "@type": "Question", "name": "La fièvre jaune peut-elle entraîner la mort ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre jaune peut être mortelle, surtout sans traitement approprié." } }, { "@type": "Question", "name": "Quels organes peuvent être affectés par la fièvre jaune ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le foie, les reins et le cœur peuvent être gravement affectés par la maladie." } }, { "@type": "Question", "name": "Les complications surviennent-elles rapidement ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent survenir dans les 7 à 10 jours suivant l'infection." } }, { "@type": "Question", "name": "Peut-on récupérer complètement après des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines personnes peuvent récupérer complètement, mais d'autres peuvent avoir des séquelles." } }, { "@type": "Question", "name": "Qui est le plus à risque de contracter la fièvre jaune ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes vivant ou voyageant dans des zones endémiques sont les plus à risque." } }, { "@type": "Question", "name": "Les voyageurs doivent-ils se faire vacciner avant de partir ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination est fortement recommandée pour les voyageurs vers des zones à risque." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un risque accru de complications graves." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées courent un risque plus élevé de maladie sévère." } }, { "@type": "Question", "name": "Les conditions de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre dans des zones avec des moustiques augmente le risque de transmission." } } ] } ] }

Sources (10000 au total)

Safer opioid supply: qualitative program evaluation.

As the overdose crisis in Canada continues to escalate in severity, novel interventions and programs are required. Safer Supply programs offer pharmaceutical-grade medication to people who use drugs t... We completed semi-structured interviews and surveys with Safer Supply participants in Ottawa, Canada. Interviews were audio-recorded, transcribed, and analyzed thematically. Descriptive statistics wer... Participants most commonly discussed Safer Supply benefits. This included programs offering a sense of community, connection, hope for the future, and increased autonomy. Participants also described p... Our research demonstrated that participants found Safer Supply to be effective and impactful for their substance use goals. While participants did discuss concerns about the program, overall, we found...

The directors of resident support program: a program evaluation of a resident well-being and support innovation.

Medical training can be a challenging time for residents both professionally and personally. Resident support programs must be able to address a range of potential experiences, be accessible and easy ... The Directors of Resident Support (DRS) program, launched in January 2021 at the Cumming School of Medicine at the University of Calgary, is a near-peer support model consisting of three faculty physi... There were 62 total contacts in the 2-year evaluation period which required a median 2 h to address (range 5 min to more than 40 h). The most common topic for contact was to discuss feedback or evalua... The DRS program has been well-utilized by residents for a variety of issues. Postgraduate Medical Education offices seeking to create resident support programs may anticipate that about 3% of resident...

Impact of a short-term pharmacy study abroad Program: student outcomes and program evaluation.

This study examined the impact of a short-term study abroad program, focusing on program evaluation, attendee satisfaction, and acquired knowledge and skills. A questionnaire survey was conducted cove... Results indicated higher female participation due to gender imbalances in pharmacy students in Egypt, with senior students recognizing the value of international experience. Attendee satisfaction was ...

A mixed-methods program evaluation of the Alda Healthcare Experience- a program to improve healthcare team communication.

Communication among interprofessional healthcare worker teams is critical to ensure a thriving and resilient workforce. We will evaluate the implementation and effectiveness of the Alda Healthcare Exp... Our outcome evaluation will assess the impact of the AHE workshop on short- and long-term improvement in interprofessional communication, stress, and professional fulfillment. The process evaluation c... Effective and efficient communication within healthcare teams is fundamental to building team cohesion that, in turn, supports individual resilience and builds positive organizational culture. The AHE... N/A....

Facilitators and barriers to monitoring and evaluation at syringe service programs.

Syringe services programs (SSPs) provide harm reduction supplies and services to people who use drugs and are often required by funders or partners to collect data from program participants. SSPs can ... Using the Consolidated Framework for Implementation Research (CFIR), we conducted 12 key informant interviews with SSP staff to describe the overall landscape of data systems at SSPs, understand facil... Four main themes emerged from our analysis: SSP M&E systems are primarily designed to be responsive to perceived SSP client needs and preferences; SSP staffing capacity influences the likelihood of mo... Our findings highlight that SSPs are not resistant to data collection and M&E, but face substantial barriers to implementation, including lack of funding and disjointed data reporting requirements. Th...